Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1631366

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1631366

Global Mycotoxin Testing Market Size Study by Type (Aflatoxin, Ochratoxin, Fumonisins, Zearalenone, Deoxynivalenol, Trichothecenes, Patulin), Technology (Chromatography- & Spectroscopy-Based, Immunoassay-Based), Sample, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Mycotoxin Testing Market is valued at approximately USD 1.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.70% over the forecast period 2024-2032. Mycotoxin testing, a crucial component of food and feed safety, is gaining prominence due to rising incidences of contamination and increasing awareness of health hazards associated with mycotoxins. These toxic secondary metabolites, produced by molds, pose significant risks to human and animal health. The industry is witnessing rapid technological advancements in detection techniques, including immunoassay- and chromatography-based methods, ensuring high sensitivity and specificity.

The escalating demand for food safety compliance, driven by stringent government regulations and global trade standards, is propelling the growth of the mycotoxin testing market. Innovations in sample preparation and detection technologies, coupled with automated solutions, are revolutionizing the efficiency of testing processes. However, challenges such as high testing costs and limited accessibility in developing regions remain significant barriers. Nevertheless, the market's expansion is underpinned by growing concerns over food security and the increasing prevalence of mycotoxins in agricultural products, particularly due to climate change.

Regionally, North America dominates the market due to its stringent regulatory framework and well-established testing infrastructure. Europe follows closely, reflecting robust demand for advanced testing technologies, particularly in countries with significant agricultural exports. Asia Pacific is anticipated to witness the highest growth rate, driven by increasing agricultural production, rising food safety awareness, and expanding regulatory mandates in emerging economies such as China and India. Meanwhile, Latin America and the Middle East & Africa offer untapped opportunities as awareness and infrastructure development improve across these regions.

Major market players included in this report are:

  • Eurofins Scientific SE
  • SGS S.A.
  • Bureau Veritas S.A.
  • Intertek Group plc
  • Romer Labs Division Holding GmbH
  • R-Biopharm AG
  • Neogen Corporation
  • Charm Sciences, Inc.
  • VICAM, A Waters Business
  • ALS Limited
  • Biomin Holding GmbH
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.

The detailed segments and sub-segments of the market are explained below:

By Type:

  • Aflatoxin
  • Ochratoxin
  • Fumonisins
  • Zearalenone
  • Deoxynivalenol
  • Trichothecenes
  • Patulin

By Technology:

  • Chromatography- & Spectroscopy-Based
  • Immunoassay-Based

By Sample:

  • Cereals & Grains
  • Nuts, Seeds & Spices
  • Dairy Products
  • Meat & Poultry
  • Processed Food
  • Beverages

By Region:

North America:

  • U.S.
  • Canada

Europe:

  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific:

  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America:

  • Brazil
  • Mexico

Middle East & Africa:

  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Key Takeaways:

  • Comprehensive market estimates and forecasts for 10 years from 2022 to 2032.
  • Regional and country-level analysis for each market segment.
  • Insights into competitive dynamics, including profiles of major players.
  • Detailed segmentation and sub-segmentation for a nuanced market understanding.
  • Strategic recommendations for stakeholders and new entrants.
  • Analysis of demand-side and supply-side drivers shaping the market.

Table of Contents

Chapter 1. Global Mycotoxin Testing Market Executive Summary

  • 1.1. Global Mycotoxin Testing Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Technology
    • 1.3.3. By Sample
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Mycotoxin Testing Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Mycotoxin Testing Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Incidences of Mycotoxin Contamination
    • 3.1.2. Stringent Government Regulations and Global Trade Standards
    • 3.1.3. Technological Advancements in Detection Methods
  • 3.2. Market Challenges
    • 3.2.1. High Testing Costs
    • 3.2.2. Limited Accessibility in Developing Regions
  • 3.3. Market Opportunities
    • 3.3.1. Growing Concerns Over Food Security
    • 3.3.2. Increasing Prevalence Due to Climate Change
    • 3.3.3. Development of Cost-effective and Rapid Testing Methods

Chapter 4. Global Mycotoxin Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Mycotoxin Testing Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Mycotoxin Testing Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Aflatoxin
    • 5.2.2. Ochratoxin
    • 5.2.3. Fumonisins
    • 5.2.4. Zearalenone
    • 5.2.5. Deoxynivalenol
    • 5.2.6. Trichothecenes
    • 5.2.7. Patulin

Chapter 6. Global Mycotoxin Testing Market Size & Forecasts by Technology 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Mycotoxin Testing Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Chromatography- & Spectroscopy-Based
    • 6.2.2. Immunoassay-Based

Chapter 7. Global Mycotoxin Testing Market Size & Forecasts by Sample 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Mycotoxin Testing Market: Sample Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Cereals & Grains
    • 7.2.2. Nuts, Seeds & Spices
    • 7.2.3. Dairy Products
    • 7.2.4. Meat & Poultry
    • 7.2.5. Processed Food
    • 7.2.6. Beverages

Chapter 8. Global Mycotoxin Testing Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Mycotoxin Testing Market
    • 8.1.1. U.S. Mycotoxin Testing Market
      • 8.1.1.1. Type Breakdown Size & Forecasts, 2022-2032
      • 8.1.1.2. Technology Breakdown Size & Forecasts, 2022-2032
      • 8.1.1.3. Sample Breakdown Size & Forecasts, 2022-2032
    • 8.1.2. Canada Mycotoxin Testing Market
      • 8.1.2.1. Type Breakdown Size & Forecasts, 2022-2032
      • 8.1.2.2. Technology Breakdown Size & Forecasts, 2022-2032
      • 8.1.2.3. Sample Breakdown Size & Forecasts, 2022-2032
  • 8.2. Europe Mycotoxin Testing Market
    • 8.2.1. UK Mycotoxin Testing Market
    • 8.2.2. Germany Mycotoxin Testing Market
    • 8.2.3. France Mycotoxin Testing Market
    • 8.2.4. Spain Mycotoxin Testing Market
    • 8.2.5. Italy Mycotoxin Testing Market
    • 8.2.6. Rest of Europe Mycotoxin Testing Market
  • 8.3. Asia-Pacific Mycotoxin Testing Market
    • 8.3.1. China Mycotoxin Testing Market
    • 8.3.2. India Mycotoxin Testing Market
    • 8.3.3. Japan Mycotoxin Testing Market
    • 8.3.4. Australia Mycotoxin Testing Market
    • 8.3.5. South Korea Mycotoxin Testing Market
    • 8.3.6. Rest of Asia Pacific Mycotoxin Testing Market
  • 8.4. Latin America Mycotoxin Testing Market
    • 8.4.1. Brazil Mycotoxin Testing Market
    • 8.4.2. Mexico Mycotoxin Testing Market
    • 8.4.3. Rest of Latin America Mycotoxin Testing Market
  • 8.5. Middle East & Africa Mycotoxin Testing Market
    • 8.5.1. Saudi Arabia Mycotoxin Testing Market
    • 8.5.2. South Africa Mycotoxin Testing Market
    • 8.5.3. Rest of Middle East & Africa Mycotoxin Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Eurofins Scientific SE
    • 9.1.2. SGS S.A.
    • 9.1.3. Bureau Veritas S.A.
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Eurofins Scientific SE
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. SGS S.A.
    • 9.3.3. Bureau Veritas S.A.
    • 9.3.4. Intertek Group plc
    • 9.3.5. Romer Labs Division Holding GmbH
    • 9.3.6. R-Biopharm AG
    • 9.3.7. Neogen Corporation
    • 9.3.8. Charm Sciences, Inc.
    • 9.3.9. VICAM, A Waters Business
    • 9.3.10. ALS Limited
    • 9.3.11. Biomin Holding GmbH
    • 9.3.12. IDEXX Laboratories, Inc.
    • 9.3.13. Thermo Fisher Scientific Inc.
    • 9.3.14. Agilent Technologies, Inc.
    • 9.3.15. PerkinElmer, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!